DR. CHITARANJAN MISHRA

DR. K. NARESH BABU, DR. KIM RAMASAMY, DR. KULSUM SAYYAD

Abstract

Purpose: To study the role of intravitreal triamcinolone acetonide (IVTA) for hypertensive retinopathy (HTR) -related macular edema (ME).

Methods: 19 patients (37 eyes) having HTR and ME were segregated into 8 (15 eyes) and 11 (22 eyes) as treatment (IVTA OU at an interval of 3 days + control of hypertension) and control group (control of hypertension) respectively.

Results: There was no difference in central foveal thickness (CFT) between both groups at 1 month. However, the CFT was lower in the treatment group ( median 152, IQR 130-205) than in the control group ( median 207.5, IQR 165-227) p=0.021 at 3 months. Compared to the baseline, there was improvement in vision in follow-up 3 months, which was significant both in the treatment (6/60 to 6/12) and the control groups (6/15 to 6/9). p=0.014 and p=0.004.

Conclusion: A decrease in the CFT and an increase in the vision occurred in both groups at 1 month and 3 months. IVTA resulted in a lesser CFT than the control arm at 3 months.